New markers in serum for lymphocyte activation for predicting allograft rejection. Neopterin and soluble interleukin-2 receptor

Clin Lab Med. 1992 Mar;12(1):99-111.

Abstract

Investigations have been reported on the use of neopterin and soluble interleukin-2 receptors as rejection markers. Each of these analytes is available as part of an easy-to-perform analytic method. Each is available in a diagnostic kit that is accurate, precise, and sensitive enough to provide good clinical information. Both of these materials have a significant relationship with the cell-mediated immune response, particularly at the level of T-cell activation. Neopterin does increase significantly in cases of transplant rejection but shows greater response to viral infection. Soluble interleukin-2 receptors increase during periods of transplant rejection but also respond during T-cell activation brought on by bacterial or viral infection. The use of these markers is best described for kidney transplants and less well documented for liver and heart transplants.

Publication types

  • Review

MeSH terms

  • Biomarkers / blood*
  • Biopterins / analogs & derivatives*
  • Biopterins / blood
  • Graft Rejection*
  • Heart Transplantation
  • Humans
  • Kidney Transplantation
  • Liver Transplantation
  • Lymphocyte Activation*
  • Neopterin
  • Receptors, Interleukin-2 / analysis*

Substances

  • Biomarkers
  • Receptors, Interleukin-2
  • Biopterins
  • Neopterin